Our own previous studies and those of others have established a significant correlation between elevated levels of CCN1 and more advanced disease and metastatic phenotypes in in vitro breast cancer models and in patients [14–17, 20, 29–33]. This evidence concerns the gene CCN1 and breast cancer.